The HBV and HDV Forum 17 meeting was held on Wednesday, November 4, 2026, in Denver, Colorado.
Materials
Introductory Remarks and Program Overview
Welcome, Forum Updates, Program Overview and Acknowledgments
Shilpa Mitra, Forum for Collaborative Research
Steering Committee Co-Chair Welcoming Remarks
Veronica Miller, Forum for Collaborative Research
Norah Terrault, Keck School of Medicine of USC
Carey Hwang, IntegerBio
Session I: Industry Rapid-Fire Updates
Industry Rapid-Fire Updates
Sue Currie, Virion Therapeutics
Christian Voitenleitner, Roche
Renee-Claude Mercier, Gilead
Susanna Tan, Mirum Pharmaceuticals
Teresa Wright, Vir Biotechnology
Charles Walworth, Monogram Biosciences / Labcorp*
Open Discussion
All Meeting Participants
Session II: HDV Clinical Trials Endpoints Working Group Updates
HDV Clinical Trials Endpoints Manuscript: Updates
Jenny Stanton, Gilead
Pietro Lampertico, University of Milan
Open Discussion
All Meeting Participants
Session III: HCC Working Group Updates
HCC Manuscript: Updates
Loey Mak, The University of Hong Kong*
Tamar Taddei, Yale/VA
Open Discussion
All Meeting Participants
* Denotes remote participation